Your browser doesn't support javascript.
loading
Liver biopsy in the real world-reporting, expert concordance and correlation with a pragmatic clinical diagnosis.
Kim, Hannah P; Idowu, Michael O; Mospan, Andrea R; Allmon, Andrew G; Roden, Michael; Newsome, Philip; Lok, Anna S; Thuluvath, Paul J; Taunk, Jawahar; Fried, Michael W; Sanyal, Arun J; Barritt, A Sidney.
Afiliación
  • Kim HP; University of North Carolina, Chapel Hill, NC, USA.
  • Idowu MO; Virginia Commonwealth University, Richmond, VA, USA.
  • Mospan AR; Target RWE, Durham, NC, USA.
  • Allmon AG; Target RWE, Durham, NC, USA.
  • Roden M; Department of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
  • Newsome P; Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany.
  • Lok AS; German Center for Diabetes Research (DZD), Partner Düsseldorf, Germany.
  • Thuluvath PJ; University of Birmingham, Birmingham, UK.
  • Taunk J; University of Michigan, Ann Arbor, MI, USA.
  • Fried MW; Mercy Medical Center, Baltimore, MD, USA.
  • Sanyal AJ; University of Maryland School of Medicine, Baltimore, MD, USA.
  • Barritt AS; Advanced Gastroenterology Associates, Palm Harbor, FL, USA.
Aliment Pharmacol Ther ; 54(11-12): 1472-1480, 2021 12.
Article en En | MEDLINE | ID: mdl-34694013
BACKGROUND: Patients with non-alcoholic steatohepatitis (NASH) and fibrosis stage ≥2 comprise a target population for pharmacotherapy. Liver biopsy, the reference standard for identifying this population, requires complete and accurate assessment of steatohepatitis and fibrosis. Aims To investigate the completeness of real-world NASH-related pathology reports, assess concordance between site pathologists and central expert interpretation of the histologic elements of NASH, and determine concordance between biopsy-diagnosed NASH and a pragmatic clinical definition of NASH. METHODS: Liver pathology reports from 222 patients across 38 TARGET-NASH sites were analysed for documentation of the histologic features of NASH. Biopsy slides were over-read by a blinded central expert pathologist. Concordance of histologic scores and interpretation was assessed. Histologic concordance with a clinical definition of NASH was determined. TARGET-NASH clinically defined NASH: elevated ALT, hepatic steatosis on biopsy or imaging and ≥1 of the following: BMI ≥30 kg/m2 , type 2 diabetes mellitus and dyslipidaemia. RESULTS: Documentation of steatosis, lobular inflammation, portal inflammation and ballooning were missing from 21%, 35%, 46% and 40% of reports, respectively. There was slight-to-fair concordance (weighted kappa 0.01-0.35) between site and central pathologists for inflammatory features, and moderate concordance (weighted kappa 0.56-0.57) for fibrosis staging. Clinical definition of NASH was 75%-91% concordant (94%-95% sensitive) with biopsy-diagnosed NASH. CONCLUSIONS: There is substantial variability in reporting and grading NASH and fibrosis staging in clinical practice. This heterogeneity may adversely impact patient assessment and translation of practice guidelines into reality. The TARGET-NASH pragmatic clinical definition may serve as a valuable tool to accurately identify NASH patients in clinical practice.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Aliment Pharmacol Ther Asunto de la revista: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Aliment Pharmacol Ther Asunto de la revista: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido